---

layout: post
category: press
title: "GV joins $50 million round in Rome Therapeutics to research ‘junk DNA’ for cancer therapies"
date: 2020-04-27 11:16:32
link: https://vrhk.co/3cRO4Ks
image: https://venturebeat.com/wp-content/uploads/2020/04/Rosana_Kapeller_Off.jpg?w=1200&strip=all
domain: venturebeat.com
author: "VentureBeat"
icon: https://venturebeat.com/wp-content/themes/vb-news/img/favicon.ico
excerpt: "Rome Therapeutics, which is using ML to explore the human genome and develop new treatments for cancer, has launched with $50 million in funding."

---

### GV joins $50 million round in Rome Therapeutics to research ‘junk DNA’ for cancer therapies

Rome Therapeutics, which is using ML to explore the human genome and develop new treatments for cancer, has launched with $50 million in funding.